Loading provider…
Loading provider…
Hematology & Oncology Physician in New York, NY
NPI: 1306003793Primary Employer
Memorial Solid Tumor Group
mskcc.org
HQ Phone
Get MD James's Phone Numberphone_androidMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2008 - 2026
NJ State Medical License
2019 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2010 - 2013
New York Presbyterian Hospital (Cornell Campus)
Residency • Internal Medicine
2007 - 2010
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 144 | 664 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 50 | 50 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 21 | 25 |
Authors: Ghassan Abou-Alfa
Journal: Hepatobiliary Surg Nutr
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
Authors: Raja Narayan, Jeffrey Drebin, Ronald Dematteo, William Jarnagin, Ghassan Abou-Alfa, Vinod Balachandran
Publication Date: 2018-06-28
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Future Oncol
Publication Date: 2018-04-17
Lead Sponsor: Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Cisplatin, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Durvalumab, DRUG: Zanidatamab
Lead Sponsor: AstraZeneca
Intervention / Treatment: DRUG: Placebo, DRUG: Capecitabine, DRUG: Rilvegostomig, DRUG: Gemcitabine/Cisplatin, DRUG: S-1 [Tegafur/Oteracil/gimeracil]
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Itraconazole (ITZ), DRUG: ABBV-400